NextWave TMS, a mental health clinic in Mississauga, Ontario, is expanding access to Deep Transcranial Magnetic Stimulation (Deep TMS) therapy for people living with treatment-resistant depression. The condition affects more than 2.5 million Canadians each year, and for many, medications alone aren’t effective.
Clinical studies have demonstrated that Deep TMS can achieve clinically meaningful symptom improvement in over 80% of patients with treatment-resistant depression. Unlike standard TMS, Deep TMS stimulates broader and deeper areas of the brain associated with mood regulation. The therapy is Health Canada-approved and has been validated in multiple clinical studies. According to Dr. Darren Holub, MD, Psychiatrist and Medical Director at NextWave TMS: “Many patients arrive at our clinic after years of trying medications that didn’t provide relief. Deep TMS offers a transformative, non-invasive solution, helping people regain control of their lives and reconnect with what matters most.”
Sessions are outpatient, require no anesthesia or downtime, and patients can continue their daily activities immediately after each treatment. Modern accelerated TMS protocols are available that can deliver tangible clinical results in only 3-5 days—far faster than antidepressant medication. Dr. Holub stated: “Deep TMS with accelerated protocols represents a critical step forward, giving patients effective alternatives to medication and traditional therapy.” The clinic collaborates closely with physicians, psychiatrists, and mental health professionals to ensure integrated care and long-term benefits.
This article is an AI-assisted summary. All facts and figures are drawn from the original report: https://menafn.com/1110997781/Mississauga-Clinic-Offers-Access-To-Breakthrough-Deep-TMS-Therapy-For-Depression